Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family member A1 pseudogene 5 (DNAJA1P5) is classified as a pseudogene located on chromosome 1[5]. Pseudogenes are genomic sequences similar to known genes but are typically non-functional due to disabling mutations, lack of regulatory elements, or genomic integration that disrupts transcription or translation[1][7][9]. The DNAJA1P5 sequence is related to the DnaJ (Hsp40) family, which comprises protein-coding genes functioning as molecular chaperones to assist heat shock protein 70 (Hsp70) in protein folding and cellular stress responses[6][12]. However, as a pseudogene, DNAJA1P5 does not encode a functional protein and is not classified as a therapeutic target, receptor, enzyme, transporter, or transcription factor[1][5][9]. Pseudogenes like DNAJA1P5 are generally not direct drug targets and rarely serve as biomarkers or have safety concerns. Recent research suggests some pseudogenes can have regulatory roles at the RNA level (for instance, by acting as non-coding RNAs or through gene conversion and recombination affecting their parent genes), but no such role has been documented for DNAJA1P5 specifically[1][7][9]. DNAJA1P5 is a non-coding pseudogene derived from the DnaJ heat shock protein family A1 gene, is not a therapeutic target, and has no known clinical or biological function, alias HEJ1[5][1][7][9]. If a functional Hsp40/DnaJ protein target is required, refer to DNAJA1 (DnaJ heat shock protein family member A1) or related homologs[6][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member A1 pseudogene 5 (DNAJA1P5).